Why did analysts raise Celanese's price targets despite its Q1 2026 earnings miss?

Analysts from JPMorgan and Morgan Stanley raised their price targets for Celanese Corporation (CE) despite its Q1 2026 earnings miss because they cited the company's margin improvement initiatives and positive outlook for 2026. The company's diversified specialty chemicals and engineered materials business is focused on operational efficiency and cost savings to drive future growth, even amid cyclical demand risks. US investors are watching the stock for its combination of near-term disappointment and optimism surrounding its recovery plans.

What strategic priorities is Celanese emphasizing to support its 2026 outlook?

Celanese is emphasizing operational efficiency and cost savings as core strategic priorities to support its 2026 outlook. These efforts are part of broader margin improvement initiatives aimed at driving future growth across its diversified specialty chemicals and engineered materials business, while managing ongoing cyclical demand risks.

Analysts Raise Celanese Price Targets Following Q1 Earnings Miss

May 8, 2026

Celanese Corp. missed Q1 2026 earnings, yet analysts from JPMorgan and Morgan Stanley raised price targets citing margin improvements and a positive 2026 outlook for its specialty chemicals division.

AD HOC NEWS

2026-02-18

Celanese Q4 Earnings Drop as Volumes Slump in Engineered Materials, Acetyls

2026-02-20

Celanese expands tech center in Michigan

2026-02-20

Celanese pivots nylon strategy amid China oversupply

2026-03-12

Celanese Director Receives Phantom Stock Compensation Award

2026-03-13

Pricing Power and Deleveraging: A Deep Dive into Celanese Corp. (CE) in 2026